1. Home
  2. DNA vs NXP Comparison

DNA vs NXP Comparison

Compare DNA & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$10.14

Market Cap

607.1M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Select Tax Free Income Portfolio

NXP

Nuveen Select Tax Free Income Portfolio

HOLD

Current Price

$14.30

Market Cap

728.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNA
NXP
Founded
2008
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
607.1M
728.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DNA
NXP
Price
$10.14
$14.30
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$10.50
N/A
AVG Volume (30 Days)
1.1M
70.0K
Earning Date
02-24-2026
01-01-0001
Dividend Yield
N/A
4.04%
EPS Growth
N/A
N/A
EPS
N/A
0.54
Revenue
$180,606,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.07
N/A
P/E Ratio
N/A
$26.81
Revenue Growth
N/A
N/A
52 Week Low
$5.00
$12.91
52 Week High
$17.58
$14.89

Technical Indicators

Market Signals
Indicator
DNA
NXP
Relative Strength Index (RSI) 57.43 65.43
Support Level $7.73 $13.89
Resistance Level $10.23 $14.19
Average True Range (ATR) 0.79 0.08
MACD 0.01 0.03
Stochastic Oscillator 69.44 100.00

Price Performance

Historical Comparison
DNA
NXP

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About NXP Nuveen Select Tax Free Income Portfolio

Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.

Share on Social Networks: